Enhanced expression of endogenous retroviruses and of TRIM28 and SETDB1 in children with food allergy.
Endogene retroviren
Kinder
Lebensmittelallergie
SETDB1
TRIM28
children
endogenous retroviruses
food allergy
Journal
Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
19
01
2022
received:
21
07
2021
accepted:
27
01
2022
entrez:
28
3
2022
pubmed:
29
3
2022
medline:
29
3
2022
Statut:
ppublish
Résumé
Human endogenous retroviruses (HERVs) represent 8% of our genome. They originate from ancestral infections and although no longer contagious they can regulate transcription of adjacent cellular genes, produce viral RNAs sensed as non-self by pattern recognition receptors, and encode viral proteins, such as Syncytin (SYN) 1 and 2, that exhibit potent immunomodulatory properties. Based on this, HERVs have been studied and proposed as relevant cofactors in several chronic inflammatory and immune-mediated diseases. HERV transcription is regulated by host TRIM28 and SET domain bifurcated histone lysine methyltransferase 1 (SETDB1), which in turn exert crucial regulatory functions on the host immune system. No studies explored the expression of HERVs, TRIM28, and SETDB1 in allergic patients. We assessed, through a polymerase chain reaction real time Taqman amplification assay, the transcription levels of pol genes of HERV-H, HERV-K, HERV-W, and of env genes of SYN1 and SYN2, as well as of TRIM28 and SETDB1 in whole blood from 32 children with IgE-mediated food allergy, 19 with food protein-induced enterocolitis syndrome (FPIES), and in healthy control children. The expression levels of pol genes of HERV-H, -K, and -W were significantly enhanced in patients with IgE-mediated FA or FPIES as compared to control subjects, while the mRNA concentrations of SYN1 and SYN2 were comparable in each group of children. Both TRIM28 and SETDB1 mRNA levels were significantly higher in allergic patients. Given the influence of HERVs and of TRIM28 and SETDB1 on innate and adaptive immune responses, their transcriptional activation in children with food allergies suggest that they might play important roles in the development of these diseases.
Sections du résumé
BACKGROUND
BACKGROUND
Human endogenous retroviruses (HERVs) represent 8% of our genome. They originate from ancestral infections and although no longer contagious they can regulate transcription of adjacent cellular genes, produce viral RNAs sensed as non-self by pattern recognition receptors, and encode viral proteins, such as Syncytin (SYN) 1 and 2, that exhibit potent immunomodulatory properties. Based on this, HERVs have been studied and proposed as relevant cofactors in several chronic inflammatory and immune-mediated diseases. HERV transcription is regulated by host TRIM28 and SET domain bifurcated histone lysine methyltransferase 1 (SETDB1), which in turn exert crucial regulatory functions on the host immune system. No studies explored the expression of HERVs, TRIM28, and SETDB1 in allergic patients.
METHODS
METHODS
We assessed, through a polymerase chain reaction real time Taqman amplification assay, the transcription levels of pol genes of HERV-H, HERV-K, HERV-W, and of env genes of SYN1 and SYN2, as well as of TRIM28 and SETDB1 in whole blood from 32 children with IgE-mediated food allergy, 19 with food protein-induced enterocolitis syndrome (FPIES), and in healthy control children.
RESULTS
RESULTS
The expression levels of pol genes of HERV-H, -K, and -W were significantly enhanced in patients with IgE-mediated FA or FPIES as compared to control subjects, while the mRNA concentrations of SYN1 and SYN2 were comparable in each group of children. Both TRIM28 and SETDB1 mRNA levels were significantly higher in allergic patients.
CONCLUSIONS
CONCLUSIONS
Given the influence of HERVs and of TRIM28 and SETDB1 on innate and adaptive immune responses, their transcriptional activation in children with food allergies suggest that they might play important roles in the development of these diseases.
Identifiants
pubmed: 35344298
doi: 10.1002/clt2.12124
pmc: PMC8967271
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12124Informations de copyright
© 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
Références
Immunol Rev. 2016 Jan;269(1):85-99
pubmed: 26683147
Bioessays. 2012 Sep;34(9):734-8
pubmed: 22736292
Clin Transl Allergy. 2020 Dec 3;10(1):56
pubmed: 33292572
Allergy. 2019 Sep;74(9):1760-1768
pubmed: 30972786
J Allergy Clin Immunol. 2021 Sep;148(3):895-901.e6
pubmed: 33891982
Clin Transl Allergy. 2020 May 25;10:15
pubmed: 32489587
Reproduction. 2016 Nov;152(5):R167-78
pubmed: 27486264
Am J Perinatol. 2019 Aug;36(10):1060-1065
pubmed: 30500959
Int J Mol Sci. 2020 Jun 01;21(11):
pubmed: 32492928
J Immunol. 2013 May 1;190(9):4470-3
pubmed: 23543754
EMBO J. 2019 Jun 17;38(12):
pubmed: 31068361
Genes Dev. 1996 Aug 15;10(16):2067-78
pubmed: 8769649
Eur J Immunol. 2010 May;40(5):1232-40
pubmed: 20148422
Clin Transl Allergy. 2016 May 04;6:16
pubmed: 27148440
J Allergy Clin Immunol. 2018 Mar;141(3):846-857
pubmed: 29519451
J Immunol. 2006 Jun 15;176(12):7636-44
pubmed: 16751411
Genes Dev. 2002 Apr 15;16(8):919-32
pubmed: 11959841
Nat Commun. 2015 Feb 24;6:6304
pubmed: 25710614
Nat Rev Microbiol. 2019 Jun;17(6):355-370
pubmed: 30962577
Clin Transl Allergy. 2022 Mar;12(3):e12124
pubmed: 35344298
J Immunol. 2021 Apr 1;206(7):1528-1539
pubmed: 33619215
Pediatrics. 2017 Aug;140(2):
pubmed: 28739655
Biol Reprod. 2020 Feb 12;102(1):185-198
pubmed: 31318021
Eur J Immunol. 2020 May;50(5):685-694
pubmed: 32012247
PLoS One. 2013 Dec 06;8(12):e80128
pubmed: 24324591
Clin Transl Allergy. 2018 Sep 28;8:38
pubmed: 30275944
Allergy. 2009 Apr;64(4):505-19
pubmed: 19210347
Science. 2016 Mar 4;351(6277):1083-7
pubmed: 26941318
J Virol Methods. 2009 Oct;161(1):98-106
pubmed: 19505508
Front Immunol. 2018 Sep 28;9:2229
pubmed: 30323812
Allergy. 2019 Jun;74(6):1166-1175
pubmed: 30762239
J Allergy Clin Immunol. 2018 Jan;141(1):41-58
pubmed: 29157945
Eur J Pediatr. 2021 Aug;180(8):2429-2434
pubmed: 33772337
Curr Opin Chem Biol. 2018 Aug;45:139-147
pubmed: 29800804
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3677-82
pubmed: 21321220
J Immunol. 2010 May 1;184(9):4708-16
pubmed: 20308632
Front Pediatr. 2020 May 14;8:244
pubmed: 32478020
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20083-8
pubmed: 23169648
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13013-8
pubmed: 14557543
Allergy. 2019 Jan;74(1):152-164
pubmed: 29779209
Allergy. 2014 Aug;69(8):1008-25
pubmed: 24909706
Genome Res. 2014 Aug;24(8):1260-70
pubmed: 24879559
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25839-25849
pubmed: 31776254
J Allergy Clin Immunol. 2014 Feb;133(2):500-10
pubmed: 24636474
Adv Immunol. 2016;132:47-69
pubmed: 27769507
Viruses. 2014 Nov 24;6(11):4609-27
pubmed: 25421890
Int J Mol Sci. 2021 Feb 23;22(4):
pubmed: 33672287
Pigment Cell Melanoma Res. 2011 Aug;24(4):656-65
pubmed: 21501418
Nature. 2010 Jan 14;463(7278):237-40
pubmed: 20075919
Front Immunol. 2018 Sep 10;9:2039
pubmed: 30250470
Immunity. 2019 Mar 19;50(3):629-644.e8
pubmed: 30737147
Nature. 2020 Apr;580(7803):386-390
pubmed: 32296174
J Allergy Clin Immunol. 2021 Jan;147(1):15-28
pubmed: 33436162
Gut. 2021 Mar;70(3):485-498
pubmed: 32503845
PLoS Genet. 2010 Mar 05;6(3):e1000869
pubmed: 20221260
Autoimmunity. 2020 Aug;53(5):283-288
pubmed: 32586158
Clin Transl Allergy. 2015 Sep 29;5:33
pubmed: 26425339
Curr Opin Allergy Clin Immunol. 2020 Feb;20(1):48-55
pubmed: 31633569
Cancers (Basel). 2020 Oct 15;12(10):
pubmed: 33076560
J Allergy Clin Immunol. 2017 Apr;139(4):1111-1126.e4
pubmed: 28167094
J Allergy Clin Immunol. 2015 May;135(5):1114-24
pubmed: 25956013
J Virol. 2016 Sep 29;90(20):9338-49
pubmed: 27512062
J Virol. 2000 Apr;74(7):3321-9
pubmed: 10708449
J Allergy Clin Immunol. 2019 Aug;144(2):600-602.e2
pubmed: 31059725